Yonhap Infomax NewsApr 23
iM Securities launches internal audit of analyst after Samchundang Pharmaceutical threatens legal action over cautious research views on oral semaglutide generic approval, raising concerns about research independence and analyst freedom in South Korea's securities industry.
#YonhapInfomax #iMSecurities #SamchundangPharmaceutical #AnalystIndependence #InternalAudit #ResearchFreedom #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=117260
Show threadClaire 🌊πŸ‡ͺπŸ‡ΊπŸ‡«πŸ‡·πŸŒFeb 5, 2025
10/ This situation serves as a stark reminder of the importance of protecting scientific integrity and resisting political censorship. Public health research must be based on evidence, not political agendas. #ProtectScience #ResearchFreedom #PublicHealth